Does anti-tnf therapy cause any change in platelet activation in ankylosing spondylitis patients? A comparative study

Journal of Thrombosis and Thrombolysis

Volumn 33, Issue 2, 2012, Pages 154-159

  Örüm, Hüseyin ^a   Pamuk, Gülsüm Emel ^a,b   Pamuk, Ömer Nuri ^a   Demir, Muzaffer ^a   Turgut, Burhan ^a  

^a TRAKYA UNIVERSITY   (Turkey)

^b Eski Yildiz Cad Park Apt No: 24 Daire: 18 ^*  (Turkey)

Author keywords

Ankylosing spondylitis; CD40L; P selectin; Platelet monocyte complexes; Platelet neutrophil complexes

Indexed keywords

C REACTIVE PROTEIN; CD40 LIGAND; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PADGEM PROTEIN; SALAZOSULFAPYRIDINE; STEROID; TUMOR NECROSIS FACTOR ANTIBODY;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; ATHEROSCLEROSIS; CLINICAL FEATURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; ENDOTHELIUM; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NEUTROPHIL; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; PROTEIN FUNCTION; THROMBOCYTE ACTIVATION;

ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET ACTIVATION; PROSPECTIVE STUDIES; SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84858865771     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-011-0663-9     Document Type: Article

References (29)

1. Pasceri V, Yeh ET (1999) A tale of two diseases: atherosclerosis and rheumatoid arthritis. Circulation 100:2124-2126
2. Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA Jr, Jansen-McWilliams L et al (1997) Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the framingham study. Am J Epidemiol 145:408-415 (Pubitemid 27084212)
3. Sari I, Okan T, Akar S, Cece H, Altay C, Secil M et al (2006) Impaired endothelial function in patients with ankylosing spondylitis. Rheumatology 45:283-286 (Pubitemid 43372841)
4. Mathieu S, Joly H, Baron G, Tournadre A, Dubost JJ, Ristori JM et al (2008) Trend towards increased arterial stiffness or intimamedia thickness in ankylosing spondylitis patients without clinically evident cardiovascular disease. Rheumatology 47:1203-1207 (Pubitemid 352038227)
5. Agewall S (2003) Is impaired flow-mediated dilatation of the brachial artery a cardiovascular risk factor? Curr Vasc Pharmacol 1:107-109
6. Sattar N (2004) Inflammation and endothelial dysfunction: intimate companions in the pathogenesis of vascular disease? Clin Sci 106:443-445
7. Gawaz M, Langer H, May AE (2005) Platelets in inflammation and atherogenesis. J Clin Invest 115:3378-3384 (Pubitemid 43121822)
8. Huo Y, Ley KF (2004) Role of platelets in the development of atherosclerosis. Trends Cardiovasc Med 14:18-22 (Pubitemid 38068207)
9. André P (2004) P-selectin in haemostasis. Br J Haematol 126:298-306
10. Vandendries ER, Furie BC, Furie B (2004) Role of P-selectin and PSGL-1 in coagulation and thrombosis. Thromb Haemost 92:459-466 (Pubitemid 39248002)
11. Joseph JE, Harrison P, Mackie IJ, Isenberg DA, Machin SJ (2001) Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis. Br J Haematol 115:451-459 (Pubitemid 34203516)
12. Sarma J, Laan CA, Alam S, Jha A, Fox KA, Dransfield I (2002) Increased platelet binding to circulating monocytes in acute coronary syndromes. Circulation 105:2166-2171 (Pubitemid 34517160)
13. Furman MI, Barnard MR, Krueger LA, Fox ML, Shilale EA, Lessard DM et al (2001) Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. J Am Coll Cardiol 38:1002-1006 (Pubitemid 32912702)
14. Inwald DP, McDowall A, Peters MJ, Callard RE, Klein NJ (2003) CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circ Res 92:1041-1048 (Pubitemid 36588504)
15. Wagner AH, Güldenzoph B, Lienenlüke B, Hecker M (2004) CD154/CD40-mediated expression of CD154 in endothelial cells: consequences for endothelial cell-monocyte interaction. Arterioscler Thromb Vasc Biol 24:715-720 (Pubitemid 38451609)
16. Van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361-368 (Pubitemid 14134775)
17. Villmow T, Kemkes-Matthes B, Matzdorff AC (2002) Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes. Thromb Research 108:139-145 (Pubitemid 36187452)
18. Krueger LA, Barnard MR, Frelinger AL, Furman MI, Michelson AD. (1997) Current protocols in cytometry. In: Robinson JP, Darzynkiewicz Z, Dean PN, Dresiler LG, Rabinovitch PS, Stewart CC, Tanke HJ, Wheeless MC (eds), 1st edn. Wiley, New York Unit 6.10, p. 1-17
19. Michelson AD, Barnard MR, Krueger LA, Valeri CR, Furman MI (2001) Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 104:1533-1537 (Pubitemid 32917347)
20. Wang F, Yan CG, Xiang HY, Xing T, Wang NS (2008) The significance of platelet activation in ankylosing spondylitis. Clin Rheumatol 27:767-769
21. Pamuk GE, Vural O, Turgut B, Demir M, Pamuk ON, Cakir N (2008) Increased platelet activation markers in rheumatoid arthritis: are they related with subclinical atherosclerosis? Platelets 19:146-154 (Pubitemid 351302382)
22. Tamura N, Kobayashi S, Kato K, Bando H, Haruta K, Oyanagi M et al (2001) Soluble CD154 in rheumatoid arthritis: elevated plasma levels in cases with vasculitis. J Rheumatol 28:2583-2590 (Pubitemid 33135639)
23. Toubi E, Shoenfeld Y (2004) The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway. Autoimmunity. 37:457-464 (Pubitemid 40123415)
24. Aukrust P, Damas JK, Solum NO (2004) Soluble CD40 ligand and platelets: self-perpetuating pathogenic loop in thrombosis and inflammation? J Am Coll Cardiol 43:2326-2328 (Pubitemid 38757606)
25. Wimalasundera R, Fexby S, Regan L, Thom SA, Hughes AD (2003) Effect of tumour necrosis factor-alpha and interleukin 1beta on endothelium-dependent relaxation in rat mesenteric resistance arteries in vitro. Br J Pharmacol 138:1285-1294 (Pubitemid 36543126)
26. Hürlimann D, Forster A, Noll G, Enseleit F, Chenevard R, Distler O et al (2002) Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation 106:2184-2187 (Pubitemid 35222210)
27. Gonzalez-Juanatey C, Testa A, Garcia-Castelo A (2004) Transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor-a antibody. Arthritis Rheum 51:447-450 (Pubitemid 38725146)
28. Baeten D, Kruithof E, Van den Bosch F, Demetter P, Van Damme N, Cuvelier C et al (2001) Immunomodulatory effects of anti-tumor necrosis factor alpha therapy on synovium in spondylarthropathy: histologic findings in eight patients from an openlabel pilot study. Arthritis Rheum 44:186-195 (Pubitemid 32113134)
29. Choe JY, Lee MY, Rheem I, Rhee MY, Park SH, Kim SK (2008) No differences of carotid intima-media thickness between young patients with ankylosing spondylitis and healthy controls. Joint Bone Spine 75:548-553